FDA — authorised 21 November 2018
- Application: NDA210656
- Marketing authorisation holder: PFIZER
- Local brand name: DAURISMO
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Daurismo in United States
FDA authorised Daurismo on 21 November 2018
Marketing authorisation
Daurismo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Daurismo approved in United States?
Yes. FDA authorised it on 21 November 2018.
Who is the marketing authorisation holder for Daurismo in United States?
PFIZER holds the US marketing authorisation.